Adicet Bio, Inc.
ACET • NASDAQ
Adicet Bio, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Chen Schor, with a market cap of $62.1M.
CEOChen Schor
Next Earnings
Upcoming earnings announcement for Adicet Bio, Inc.
Date
Tuesday, May 5, 2026 (in a month)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$3.05
Earnings History
Past 12 earnings reports for Adicet Bio, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 12, 2026 | Q4 2025 | -$2.94Est: -$3.08 | +4.5% | -Est: $2.9M | -100.0% |  10-K |
| Nov 5, 2025 | Q3 2025 | -$0.29Est: -$0.29 | 0.0% | - | — | 10-Q |
| Aug 7, 2025 | Q2 2025 | -$0.34Est: -$0.31 | -9.7% | - | — | 10-Q |
| May 6, 2025 | Q1 2025 | -$0.31Est: -$0.34 | +8.8% | - | — | 10-Q |
| Mar 6, 2025 | Q4 2024 | -$0.32Est: -$0.35 | +8.6% | - | — | 10-K |
| Nov 6, 2024 | Q3 2024 | -$0.34Est: -$0.35 | +2.9% | - | — | 10-Q |
| Aug 13, 2024 | Q2 2024 | -$0.33Est: -$0.36 | +8.3% | -Est: $620.0K | -100.0% | 10-Q |
| May 14, 2024 | Q1 2024 | -$0.35Est: -$0.58 | +39.7% | - | — | 10-Q |
| Mar 19, 2024 | Q4 2023 | -$0.69Est: -$0.69 | 0.0% | -Est: $620.0K | -100.0% | 10-K |
| Nov 8, 2023 | Q3 2023 | -$0.71Est: -$0.74 | +4.1% | -Est: $1.1M | -100.0% | — |
| Aug 9, 2023 | Q2 2023 | -$0.75Est: -$0.68 | -10.3% | -Est: $12.7M | -100.0% | 10-Q |
| May 9, 2023 | Q1 2023 | -$0.72Est: -$0.69 | -4.3% | - | — | — |